Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 586 Issue 7830, 22 October 2020

Vaccine design

The cover image draws on aspects of Bauhaus artist Paul Klee’s famous notebooks to reimagine the quest for a vaccine against SARS-CoV-2. The drive to create an effective vaccine to mitigate the COVID-19 pandemic has seen researchers move from genetic sequence of the virus to clinical trials at unprecedented speed. This week’s issue features a number of papers that probe design strategies and clinical trial results for vaccine candidates to combat the virus. In addition, a Review presents a round-up of vaccines in development, noting that signs so far suggest that a safe and effective vaccine could be realized on a timescale of months rather than years.

Cover image: Nik Spencer for Nature.

This Week

Top of page ⤴

News in Focus

Top of page ⤴

Books & Arts

Top of page ⤴

Opinion

Top of page ⤴

Work

Top of page ⤴

Research

  • News & Views

    • Leading COVID-19 vaccine candidates have progressed through laboratory tests at record speed. Two early clinical trials suggest that immunization delivers a favourable immune response and safety profile, but questions remain.

      • Christian Gaebler
      • Michel C. Nussenzweig
      News & Views
    • Sequencing the genomes of individual skin cells called melanocytes has revealed a rich landscape of DNA changes. These insights shed light on the origins of melanoma, an aggressive type of cancer.

      • Inigo Martincorena
      News & Views
    • An analysis of seismic data reveals the location and quantity of melted rock, known as melt, in Earth’s upper mantle. The results show how these factors are correlated with the movement of the planet’s tectonic plates.

      • Laura Cobden
      News & Views
  • Reviews

    • The findings of a World Health Organization expert working group that is developing animal models to test vaccines and therapeutic agents for the treatment of COVID-19, and their relevance for preclinical testing, are reviewed.

      • César Muñoz-Fontela
      • William E. Dowling
      • Dan H. Barouch
      Review Article
  • Articles

  • Matters Arising

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Nature Outlook

  • As bacteria that cause infection adapt to withstand antibiotics, the potential for antimicrobial resistance to cause a global health crisis looms large. Scientists and policymakers are working together to find ways to fight back against this threat.

    Nature Outlook
Top of page ⤴
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links